SRIT India IPO GMP signals 25.38% premium over issue price
In short
SRIT India IPO has a GMP of ₹33. Based on that, the shares could list at ₹163 each, which is 25.38% above the top of the issue price range.
This matters because a higher GMP can point to stronger listing demand. The report does not give the full subscription data, so the real listing result is still unknown.
What the reporting says
SRIT India IPO showed a GMP of ₹33, with the shares seen listing at ₹163 apiece, or 25.38% above the upper end of the issue price. The publisher-supplied summary does not provide the full subscription numbers or review details in the available text. The immediate takeaway is a strong grey-market premium, while the actual listing outcome remains uncertain.
Why it matters
SRIT India IPO is showing a grey market premium of ₹33, and the shares are being valued at around ₹163 apiece, or 25.38% above the upper end of the issue price. The available reporting does not include full subscription figures or official listing terms. The key market implication is stronger expected demand, but the actual listing performance is not known yet.